Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBT: 2010-2025

Historic EBT for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $1.2 million.

  • Cryo Cell International's EBT fell 1404.99% to $1.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $1.5 million, marking a year-over-year increase of 11176.35%. This contributed to the annual value of $2.8 million for FY2024, which is 12098.19% up from last year.
  • Per Cryo Cell International's latest filing, its EBT stood at $1.2 million for Q3 2025, which was down 1404.99% from $575103.0 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's EBT peaked at $1.6 million during Q2 2021, and registered a low of -$16.0 million during Q4 2023.
  • For the 5-year period, Cryo Cell International's EBT averaged around -$122914.6, with its median value being $899780.0 (2022).
  • In the last 5 years, Cryo Cell International's EBT plummeted by 266913.29% in 2023 and then soared by 32497.58% in 2024.
  • Over the past 5 years, Cryo Cell International's EBT (Quarter) stood at -$1.2 million in 2021, then soared by 150.05% to $622508.0 in 2022, then crashed by 2669.13% to -$16.0 million in 2023, then soared by 94.73% to -$842434.0 in 2024, then skyrocketed by 240.78% to $1.2 million in 2025.
  • Its EBT stands at $1.2 million for Q3 2025, versus $575103.0 for Q2 2025 and $533718.0 for Q1 2025.